Outcome Study – Cardiovascular Focus

This study will explore the health benefits of once-weekly Tirzepatide with people who have a history of cardiovascular problems or risk factors; without diabetes.
Clinical Description:
This study will investigate the effect of Tirzepatide on the reduction of morbidity and mortality in adults living with obesity/heart problems and provide any additional evidence of other improvements for this population. Tirzepatide has the potential of demonstrating clinically meaningful improvements in outcomes associated with weight loss.
Target Age/Sex:
40+ years old, Male & Female with Obesity & Heart Problems
During this study, participants will receive cardiovascular disease related education/materials, medical condition education, weight-loss counseling, body trackers focusing on healthy lifestyles and improved outcomes.
Study Length:
Information Request

Information Request

To request additional information please call 208-522-6005 or email rockymountainclinicalresearch@idahomed.com or complete the form below.